Parabilis Medicines Shares Rocket Following Record Biotech IPO
June 10, 2026
Oncology-focused drug company nabs $670 million in scorching stock-market debut.
Search
RECENT PRESS RELEASES
Related Post
Parabilis Medicines Shares Rocket Following Record Biotech IPO
June 10, 2026
Oncology-focused drug company nabs $670 million in scorching stock-market debut.
Search
RECENT PRESS RELEASES
Related Post